Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The way forward.
AbouZahr C, Cleland J, Coullare F, Macfarlane SB, Notzon FC, Setel P, Szreter S; Monitoring of Vital Events (MoVE) writing group; Anderson RN, Bawah AA, Betrán AP, Binka F, Bundhamcharoen K, Castro R, Evans T, Figueroa X, George CK, Gollogly L, Gonzalez R, Grzebien DR, Hill K, Huang Z, Hull TH, Inoue M, Jakob R, Jha P, Jiang Y, Laurenti R, Li X, Lievesley D, Lopez AD, Fat DM, Merialdi M, Mikkelsen L, Nien JK, Rao C, Rao K, Sankoh O, Shibuya K, Soleman N, Stout S, Tangcharoensathien V, van der Maas PJ, Wu F, Yang G, Zhang S. AbouZahr C, et al. Among authors: stout s. Lancet. 2007 Nov 24;370(9601):1791-9. doi: 10.1016/S0140-6736(07)61310-5. Epub 2007 Oct 29. Lancet. 2007. PMID: 18029003
A scandal of invisibility: making everyone count by counting everyone.
Setel PW, Macfarlane SB, Szreter S, Mikkelsen L, Jha P, Stout S, AbouZahr C; Monitoring of Vital Events. Setel PW, et al. Among authors: stout s. Lancet. 2007 Nov 3;370(9598):1569-77. doi: 10.1016/S0140-6736(07)61307-5. Lancet. 2007. PMID: 17992727 No abstract available.
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial.
Wagemann O, Liu H, Wang G, Shi X, Bittner T, Scelsi MA, Farlow MR, Clifford DB, Supnet-Bell C, Santacruz AM, Aschenbrenner AJ, Hassenstab JJ, Benzinger TLS, Gordon BA, Coalier KA, Cruchaga C, Ibanez L, Perrin RJ, Xiong C, Li Y, Morris JC, Lah JJ, Berman SB, Roberson ED, van Dyck CH, Galasko D, Gauthier S, Hsiung GR, Brooks WS, Pariente J, Mummery CJ, Day GS, Ringman JM, Mendez PC, St George-Hyslop P, Fox NC, Suzuki K, Okhravi HR, Chhatwal J, Levin J, Jucker M, Sims JR, Holdridge KC, Proctor NK, Yaari R, Andersen SW, Mancini M, Llibre-Guerra J, Bateman RJ, McDade E; Dominantly Inherited Alzheimer Network–Trials Unit. Wagemann O, et al. JAMA Neurol. 2024 Apr 29:e240991. doi: 10.1001/jamaneurol.2024.0991. Online ahead of print. JAMA Neurol. 2024. PMID: 38683602 Free PMC article.
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study.
Wisch JK, McKay NS, Boerwinkle AH, Kennedy J, Flores S, Handen BL, Christian BT, Head E, Mapstone M, Rafii MS, O'Bryant SE, Price JC, Laymon CM, Krinsky-McHale SJ, Lai F, Rosas HD, Hartley SL, Zaman S, Lott IT, Tudorascu D, Zammit M, Brickman AM, Lee JH, Bird TD, Cohen A, Chrem P, Daniels A, Chhatwal JP, Cruchaga C, Ibanez L, Jucker M, Karch CM, Day GS, Lee JH, Levin J, Llibre-Guerra J, Li Y, Lopera F, Roh JH, Ringman JM, Supnet-Bell C, van Dyck CH, Xiong C, Wang G, Morris JC, McDade E, Bateman RJ, Benzinger TLS, Gordon BA, Ances BM; Alzheimer's Biomarker Consortium-Down syndrome; Dominantly Inherited Alzheimer Network. Wisch JK, et al. Lancet Neurol. 2024 May;23(5):500-510. doi: 10.1016/S1474-4422(24)00084-X. Lancet Neurol. 2024. PMID: 38631766
Doxepin-Associated Hypoglycemia in an Ambulatory Nondiabetic Patient.
Hashmi HZ, Kaur J, Stout SC, Drake T. Hashmi HZ, et al. Among authors: stout sc. Prim Care Companion CNS Disord. 2023 Jul 6;25(4):22cr03367. doi: 10.4088/PCC.22cr03367. Prim Care Companion CNS Disord. 2023. PMID: 37419456 Free article. No abstract available.
Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's disease.
Nicosia J, Aschenbrenner AJ, Balota DA, Sliwinski MJ, Tahan M, Adams S, Stout SS, Wilks H, Gordon BA, Benzinger TLS, Fagan AM, Xiong C, Bateman RJ, Morris JC, Hassenstab J. Nicosia J, et al. Among authors: stout ss. J Int Neuropsychol Soc. 2023 Jun;29(5):459-471. doi: 10.1017/S135561772200042X. Epub 2022 Sep 5. J Int Neuropsychol Soc. 2023. PMID: 36062528 Free PMC article.
230 results